Elevance Health price target raised to $395 from $364 at Leerink
Bullish on target revision.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish on target revision.
What happened, with direct paths to the underlying reporting
ELV target raised to $395 from $364 by Leerink Partners.
Target: $395
Posted price: $369.28
Analyst firm: Leerink Partners
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.